Insider Transactions in Q4 2021 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,552
-37.29%
|
$5,302,416
$258.49 P/Share
|
|
Dec 29
2021
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,750
+43.69%
|
$1,581,750
$37.18 P/Share
|
|
Nov 12
2021
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Indirect |
4,000
+50.0%
|
-
|
|
Nov 12
2021
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Direct |
4,000
-23.7%
|
-
|
|
Nov 11
2021
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Direct |
4,000
+19.16%
|
-
|
|
Nov 11
2021
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Indirect |
4,000
-6.25%
|
-
|
|
Nov 11
2021
|
Jon M Foster EVP and COO |
SELL
Open market or private sale
|
Direct |
16,294
-83.73%
|
$3,943,148
$242.05 P/Share
|
|
Nov 10
2021
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
2,052
-31.2%
|
$504,792
$246.23 P/Share
|
|
Nov 10
2021
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Open market or private sale
|
Direct |
8,252
-18.19%
|
$2,029,992
$246.25 P/Share
|
|
Nov 09
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
3,364
-100.0%
|
$837,636
$249.61 P/Share
|
|
Nov 09
2021
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,081
-51.18%
|
$4,201,926
$246.14 P/Share
|
|
Nov 09
2021
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,375
+50.0%
|
$1,568,625
$47.97 P/Share
|
|
Nov 08
2021
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
6,748
-12.95%
|
$1,666,756
$247.63 P/Share
|
|
Nov 08
2021
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.35%
|
$330,000
$22.95 P/Share
|
|
Nov 08
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,986
-24.95%
|
$1,478,542
$247.63 P/Share
|
|
Nov 08
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
8,095
+15.2%
|
$1,149,490
$142.15 P/Share
|
|
Nov 05
2021
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,163
-43.96%
|
$1,528,424
$248.27 P/Share
|
|
Nov 05
2021
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,640
+32.91%
|
$798,000
$75.77 P/Share
|
|
Nov 05
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Open market or private sale
|
Direct |
2,100
-7.02%
|
$529,200
$252.94 P/Share
|
|
Nov 04
2021
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
20,647
-26.25%
|
$5,161,750
$250.0 P/Share
|
|
Nov 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
3,815
-30.06%
|
$953,750
$250.48 P/Share
|
|
Nov 03
2021
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
200
-0.34%
|
-
|
|
Nov 03
2021
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
9,353
-10.63%
|
$2,338,250
$250.0 P/Share
|
|
Nov 03
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,324
-56.24%
|
$1,081,000
$250.0 P/Share
|
|
Nov 03
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,688
+50.0%
|
$530,472
$69.58 P/Share
|
|
Nov 02
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,510
-26.22%
|
$1,118,480
$248.44 P/Share
|
|
Nov 02
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,325
+21.97%
|
$482,850
$58.47 P/Share
|
|
Nov 02
2021
|
Samuel N Hazen CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.58%
|
$12,550,000
$251.75 P/Share
|
|
Oct 29
2021
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,790
-17.23%
|
$19,447,500
$250.46 P/Share
|
|
Oct 29
2021
|
Samuel N Hazen CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
152,625
+25.27%
|
$7,173,375
$47.97 P/Share
|
|
Oct 29
2021
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
40,073
-31.29%
|
$10,018,250
$250.46 P/Share
|
|
Oct 29
2021
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
78,625
+38.04%
|
$3,695,375
$47.97 P/Share
|
|
Oct 29
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3,087
-9.35%
|
$771,750
$250.46 P/Share
|
|
Oct 29
2021
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,260
+13.75%
|
$415,540
$79.8 P/Share
|
|
Oct 27
2021
|
Charles J Hall Group President |
SELL
Bona fide gift
|
Direct |
4,170
-2.14%
|
-
|